SG52540A1 - Veterinary composition - Google Patents

Veterinary composition

Info

Publication number
SG52540A1
SG52540A1 SG1996005767A SG1996005767A SG52540A1 SG 52540 A1 SG52540 A1 SG 52540A1 SG 1996005767 A SG1996005767 A SG 1996005767A SG 1996005767 A SG1996005767 A SG 1996005767A SG 52540 A1 SG52540 A1 SG 52540A1
Authority
SG
Singapore
Prior art keywords
veterinary composition
composition
animals
stable
preparation
Prior art date
Application number
SG1996005767A
Other languages
English (en)
Inventor
Stig-Goran Arthur Olovson
Ake Gunnar Pilbrant
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SG52540A1 publication Critical patent/SG52540A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1996005767A 1993-04-30 1994-04-26 Veterinary composition SG52540A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939301489A SE9301489D0 (sv) 1993-04-30 1993-04-30 Veterinary composition

Publications (1)

Publication Number Publication Date
SG52540A1 true SG52540A1 (en) 1998-09-28

Family

ID=20389791

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996005767A SG52540A1 (en) 1993-04-30 1994-04-26 Veterinary composition

Country Status (33)

Country Link
US (1) US5731002A (zh)
EP (1) EP0696921B1 (zh)
JP (1) JP3872509B2 (zh)
KR (1) KR100324451B1 (zh)
CN (1) CN1100570C (zh)
AT (1) ATE199060T1 (zh)
AU (1) AU678830B2 (zh)
BR (1) BR9406363A (zh)
CZ (1) CZ285191B6 (zh)
DE (1) DE69426669T2 (zh)
DK (1) DK0696921T3 (zh)
EE (1) EE03137B1 (zh)
EG (1) EG20401A (zh)
ES (1) ES2155473T3 (zh)
FI (1) FI955124A0 (zh)
GR (1) GR3035831T3 (zh)
HR (1) HRP940267A2 (zh)
HU (1) HUT74868A (zh)
IL (1) IL109245A (zh)
IS (1) IS1694B (zh)
LT (1) LT3263B (zh)
MA (1) MA23170A1 (zh)
NO (1) NO312435B1 (zh)
NZ (1) NZ265728A (zh)
PL (1) PL176755B1 (zh)
PT (1) PT696921E (zh)
RU (1) RU2131267C1 (zh)
SE (1) SE9301489D0 (zh)
SG (1) SG52540A1 (zh)
SK (1) SK280465B6 (zh)
TN (1) TNSN94035A1 (zh)
WO (1) WO1994025070A1 (zh)
YU (1) YU22794A (zh)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
ES2194515T3 (es) * 1998-10-06 2003-11-16 Mars Uk Ltd Estereotipia en animales.
ES2216870T3 (es) * 1999-02-23 2004-11-01 MERCK & CO., INC. Composicion farmaceutica que contiene inhibidores de la bomba de protones.
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
KR20030059318A (ko) 2000-12-07 2003-07-07 알타나 파마 아게 산 불안정성 활성 성분을 포함하는 현탁액 형태의 약학 제제
DE10061135C1 (de) * 2000-12-07 2002-11-07 Byk Gulden Lomberg Chem Fab Pharmazeutische Zubereitung in Form einer Paste enthaltend einen säurelabilen Wirkstoff
SI1341524T1 (sl) * 2000-12-07 2012-02-29 Nycomed Gmbh Farmacevtski pripravek v obliki paste, ki obsega kislinsko labilno učinkovino
US20020192299A1 (en) * 2000-12-28 2002-12-19 Rajneesh Taneja Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040081671A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
US20040006109A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
JP5148813B2 (ja) * 2002-07-03 2013-02-20 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド プロトンポンプ阻害剤の液体剤形
US20040005362A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20070053981A1 (en) * 2003-07-11 2007-03-08 Eva Blychert Solid composition comprising a proton pump inhibitor
WO2005007115A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
EP1718303A4 (en) * 2004-02-10 2010-09-01 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
GB0403165D0 (en) * 2004-02-12 2004-03-17 Ct Novel uses for proton pump inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
EP1698233A1 (en) * 2005-03-01 2006-09-06 Bayer HealthCare AG Reduction of digestibility of phosphorus in animal nutrition
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
EP2012756A4 (en) * 2006-04-20 2013-01-23 Inventia Healthcare Private Ltd MULTI-UNIT COMPOSITIONS
CH698658B1 (de) * 2006-04-24 2009-09-30 Mepha Ag Orale pharmazeutische Formulierung mit schneller Freisetzung für Pyridylmethylsulfinyl-Benzimidazole.
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
CA2658804A1 (en) 2006-07-25 2008-01-31 Vecta Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with ppi
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2219643B1 (en) * 2007-11-15 2012-05-16 Novartis AG Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener
US20090227633A1 (en) * 2008-03-04 2009-09-10 Bassam Damaj Methods to inhibit tumor cell growth by using proton pump inhibitors
WO2013058996A1 (en) * 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2017185123A1 (en) * 2016-04-29 2017-11-02 Alan Thompson Veterinary composition
CN107468652A (zh) * 2016-06-07 2017-12-15 北京新领先医药科技发展有限公司 一种固体干混悬温敏凝胶剂及其制备方法
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CA3033065A1 (en) * 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL22368A (en) * 1963-11-19 1969-01-29 Merck & Co Inc 2,5(or 6)-bis-heteroaryl substituted benzazoles
BE792990A (fr) * 1971-12-23 1973-06-19 Shell Int Research Procede de lutte contre les endoparasites chez les chevaux
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5215974A (en) * 1986-11-21 1993-06-01 Aktiebolaget Hassle Certain pyridyl[(methylthio- or methyl sulfinyl)-2 benzimidazol-2-yl]N-methyl phosphonates useful for treating gastric-acid secretion related diseases
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
YU48263B (sh) 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
JP5556818B2 (ja) 2009-09-18 2014-07-23 旭硝子株式会社 二次電池用非水電解液

Also Published As

Publication number Publication date
SE9301489D0 (sv) 1993-04-30
JP3872509B2 (ja) 2007-01-24
IS4146A (is) 1994-10-31
MA23170A1 (fr) 1994-12-31
AU6693894A (en) 1994-11-21
PL176755B1 (pl) 1999-07-30
HUT74868A (en) 1997-02-28
KR100324451B1 (ko) 2002-11-01
CZ285191B6 (cs) 1999-06-16
GR3035831T3 (en) 2001-08-31
CZ282595A3 (en) 1996-04-17
IL109245A0 (en) 1994-11-28
EG20401A (en) 1999-02-28
WO1994025070A1 (en) 1994-11-10
LTIP1920A (en) 1994-11-25
NO312435B1 (no) 2002-05-13
EE03137B1 (et) 1998-12-15
JPH08509493A (ja) 1996-10-08
PL311276A1 (en) 1996-02-05
TNSN94035A1 (fr) 1995-04-25
HRP940267A2 (en) 1996-10-31
LT3263B (en) 1995-05-25
BR9406363A (pt) 1996-02-27
AU678830B2 (en) 1997-06-12
YU22794A (sh) 1998-05-15
HU9503085D0 (en) 1995-12-28
US5731002A (en) 1998-03-24
IL109245A (en) 2000-07-16
FI955124A (fi) 1995-10-27
NO954240L (no) 1995-10-23
IS1694B (is) 1998-04-20
NZ265728A (en) 1996-12-20
EP0696921A1 (en) 1996-02-21
DK0696921T3 (da) 2001-03-19
PT696921E (pt) 2001-06-29
CN1100570C (zh) 2003-02-05
ATE199060T1 (de) 2001-02-15
NO954240D0 (no) 1995-10-23
DE69426669D1 (de) 2001-03-15
EP0696921B1 (en) 2001-02-07
DE69426669T2 (de) 2001-07-05
FI955124A0 (fi) 1995-10-27
SK135495A3 (en) 1997-03-05
SK280465B6 (sk) 2000-02-14
ES2155473T3 (es) 2001-05-16
RU2131267C1 (ru) 1999-06-10
CN1122109A (zh) 1996-05-08

Similar Documents

Publication Publication Date Title
IL109245A0 (en) Veterinary composition comprising a proton pump inhibitor
BR9604803A (pt) Composição farmacêutica para administração oral
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
GEP20063773B (en) Steroid Sulphatase Inhibitors
BG105754A (en) Pharmaceutical composition containing proton pump inhibitors
PL316079A1 (en) Antiussive composition containing an antitussive agent and benzidamine
ES8703742A1 (es) Procedimiento para preparar un agente acuoso esteril de ac- cion retardada y prolongada,de un peptido o de una proteina
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor
HK1032064A1 (en) Bile acid salts of metals with physiological action and the use thereof in therapy.
MX9710093A (es) Uso de aminas alilicas.
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
ZA945431B (en) Use of benzydamine in the treatment of pathological conditions caused by TNF
AU6037494A (en) Use of active substances in the therapy of certain diseases, process for preparing a pharmaceutical composition for that purpose and pharmaceutical compositions thus prepared
UA885A1 (uk) Засiб для лiкуваhhя шлуhково-кишкових захворюваhь з озhаками дiареї
IT1269827B (it) Bicarbonato di lidocaina, suo uso farmaceutico e composizioni che lo contengono
UA7971C2 (uk) Спосіб профілактики післяпологових захворювань корів
HUP9904544A1 (hu) Nimeszulid alkalmazása neurodegeneratív állapotok kezelésére szolgáló gyógyszerkészítmények előállítására
MX9600856A (es) Preparacion farmaceutica de unidades multiples, que contienen un inhibidor de la bomba de protones.